Prolonged neuromuscular block associated with mivacurium.

Abstract excerpt

Mivacurium is a relatively new short-acting nondepolarizing neuromuscular blocker. A recommended dose of 0.15-0.2 mg kg-1 provides tracheal intubating conditions within 2.5 min and duration of action of 15-30 min, making it a possible alternative to suxamethonium for short procedures requiring tracheal intubation. However, in common with suxamethonium its metabolism depends primarily on plasma cholinesterase and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Cholinesterases
• Share to Genotype